MAPC treatment of brain injuries and diseases
US10117900B2 · kind B2 · utility
3Cited by
24References
19Claims
0Family size
Assignees
Inventors
Key dates
| Filing date | Jan 23, 2007 |
| Grant date | Nov 6, 2018 |
| Priority date | — |
| Expiry date | Apr 22, 2031 |
Classification
- Technology area (CPC A)Human Necessities
- CPC primaryA61P25/00
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The invention relates to the treatment of various injuries, disorders, dysfunctions, diseases, and the like of the brain with MAPCs, particularly in some aspects, to the treatment of the same resulting from hypoxia, including that caused by systemic hypoxia and that caused by insufficient blood supply. In some further particulars the invention relates, for example, to the treatment of hypoxic ischemic brain injury with MAPCs, in children for example, and to the treatment of cortical infarcts and stroke with MAPCs in adults, for example.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.